111 filings
Page 3 of 6
6-K
tqzmwhk5qol mndga
26 Nov 21
Current report (foreign)
6:23am
6-K
s0am58fhax0n5o3 3q06
16 Nov 21
Current report (foreign)
6:03am
6-K
p828 kxbh8z
1 Nov 21
Results of General Meeting
5:30pm
EFFECT
lgk335wr0lc2jk2v
25 Oct 21
Notice of effectiveness
12:15am
424B5
ytg ifri0y14g
22 Oct 21
Prospectus supplement for primary offering
4:34pm
6-K
8z3rerhds
21 Oct 21
Silence Therapeutics Provides mRNAi GOLD™ Platform and Pipeline Updates at 2021 R&D Day
8:45am
EFFECT
bemc1jubzlbzcq 7456
21 Oct 21
Notice of effectiveness
12:15am
EFFECT
bn5nfr5fc7nrse4
21 Oct 21
Notice of effectiveness
12:15am
UPLOAD
9plqy6tqpqika55 ygqn
20 Oct 21
Letter from SEC
12:00am
CORRESP
qg2czu
20 Oct 21
Correspondence with SEC
12:00am
POS AM
yzx8qyu
18 Oct 21
Prospectus update (post-effective amendment)
5:29pm
POS AM
5s2tfepfyootcj2t
15 Oct 21
Prospectus update (post-effective amendment)
7:50am
F-3
zv9cp pb33xqc32
15 Oct 21
Shelf registration (foreign)
7:41am
6-K/A
7s8lubc995ux7wnvdaq
15 Oct 21
Current report (foreign) (amended)
7:19am
6-K
0yo46t mw
15 Oct 21
Notice of General Meeting to be held on 1Â November 2021
7:15am
6-K
6hawc
12 Aug 21
Current report (foreign)
4:38pm
6-K
lrmzc42dmn418ya7l
12 Aug 21
Silence Therapeutics Reports Half-Year 2021 Results
4:30pm
6-K
niknk9p9zzr3
15 Jun 21
Results of Annual General Meeting
4:30pm
6-K
i5fjnb1 3g3tr
7 Jun 21
Preclinical data at EHA support recently reported positive topline clinical data for SLN124 in healthy volunteers
7:15am
6-K
hqgx6 mjwd53
25 May 21
Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment for Ongoing siRNA Collaboration
6:30am